20 states excel at protecting the vulnerable from COVID-19

Dave Pearson | | Health Exec | Management
Covid Map

Using such metrics as pledges of free vaccine when one becomes available, adoption of telemedicine and per-capita COVID relief monies, WalletHub has ranked all the states plus the District of Columbia in order of most to least supportive of at-risk populations during the pandemic.

Here’s a countdown of the 20 best at that task in the eyes of the popular personal-finance website:

20.  Louisiana

19.  New Jersey

18.  Nevada

17.  Connecticut

16.  Wyoming

15.  Oregon

14.  Hawaii

13.  Washington

12.  New York

11.  Maryland

10.  Minnesota

9.  Kentucky

8.  Colorado

7.  Vermont

6.  New Mexico

5.  North Dakota

4.  Maine

3.  Rhode Island

2.  District of Columbia

1.  Massachusetts

For the full rankings, explanations of the metrics and the rest of the reporting, click here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

DEA wants to permanently anchor some COVID-era prescription regulations
Sesame Street is coming to NewYork-Presbyterian Hospital
Q&A: Vulnerable patients hit hardest by anesthesia reimbursement cuts
Hospital sued for $900K after man’s face ignites during surgery
Dental chain involved in ransomware coverup fined $350K
Healthcare, AI top list of fastest growing jobs

Around the web

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.